TUMOR INFILTRATING LYMPHOCYTES AND PROGRAMMED DEATH LIGAND 1 (PD-L1) EXPRESSION IN DIFFUSE AND ANAPLASTIC GLIOMAS

被引:0
|
作者
Berghoff, A. S. [1 ]
Kiesel, B. [2 ]
Widhalm, G. [2 ]
Wilhelm, D. [1 ]
Rajky, O. [1 ]
Kurscheid, S. [3 ]
Hegi, M. [4 ]
Woehrer, A. [5 ]
Marosi, C. [1 ]
Preusser, M. [1 ]
机构
[1] Med Univ Vienna, Dept Med, Vienna, Austria
[2] Med Univ Vienna, Dept Neurosurg, Vienna, Austria
[3] Australian Natl Univ, John Curtin Sch Med Res, Dept Genome Sci, Canberra, ACT, Australia
[4] Univ Lausanne Hosp, Dept Clin Neurosci, Serv Neurosurg, Lab Brain Tumor Biol & Genet, Lausanne, Swaziland
[5] Med Univ Vienna, Inst Neurol, Vienna, Austria
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P04.09
引用
收藏
页码:26 / 26
页数:1
相关论文
共 50 条
  • [1] Programmed death ligand 1 (PD-L1) expression and tumor infiltrating lymphocytes in diffuse and anaplastic gliomas
    Berghoff, A. S.
    Kiesel, B.
    Widhalm, G.
    Rajky, O.
    Ricken, G.
    Woehrer, A.
    Dieckmann, K.
    Zielinski, C. C.
    Marosi, C.
    Preusser, M.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S593 - S593
  • [2] Expression of programmed cell death ligand 1 (PD-L1) and prevalence of tumor-infiltrating lymphocytes (TILs) in chordoma
    Feng, Yong
    Shen, Jacson
    Gao, Yan
    Liao, Yunfei
    Cote, Gregory
    Choy, Edwin
    Chebib, Ivan
    Mankin, Henry
    Hornicek, Francis
    Duan, Zhenfeng
    ONCOTARGET, 2015, 6 (13) : 11139 - 11149
  • [3] Expression of programmed death ligand-1 (PD-L1) and tumor infiltrating lymphocytes (TILs) in breast carcinoma and their clinical significance
    Mondal, Santosh Kumar
    Bhattacharya, Saptarshi
    Sarkar, Aditya Prasad
    Saha, Rama
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (SUPPL 1) : S81 - S86
  • [4] Tumour-infiltrating lymphocytes and expression of programmed death ligand 1 (PD-L1) in melanoma brain metastases
    Berghoff, Anna Sophie
    Ricken, Gerda
    Widhalm, Georg
    Rajky, Orsolya
    Dieckmann, Karin
    Birner, Peter
    Bartsch, Rupert
    Hoeller, Christoph
    Preusser, Matthias
    HISTOPATHOLOGY, 2015, 66 (02) : 289 - 299
  • [5] Expression of programmed death-1 ligand (PD-L1) in tumor-infiltrating lymphocytes is associated with favorable spinal chordoma prognosis
    Zou, Ming-Xiang
    Peng, An-Bo
    Lv, Guo-Hua
    Wang, Xiao-Bin
    Li, Jing
    She, Xiao-Ling
    Jiang, Yi
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2016, 8 (07): : 3274 - 3287
  • [6] Correlation Between Programmed Death-1 (PD-1) Expression in Tumor Infiltrating Lymphocytes and Programmed Death Ligand-1 (PD-L1) Expression in Non -Small Cell Lung Carcinoma
    Driver, Brandon
    Miller, Ross A.
    Deavers, Michael
    Tacha, David
    Bernicker, Eric
    Cagle, Philip T.
    MODERN PATHOLOGY, 2017, 30 : 475A - 475A
  • [7] Correlation Between Programmed Death-1 (PD-1) Expression in Tumor Infiltrating Lymphocytes and Programmed Death Ligand-1 (PD-L1) Expression in Non-Small Cell Lung Carcinoma
    Driver, Brandon
    Miller, Ross A.
    Deavers, Michael
    Tacha, David
    Bernicker, Eric
    Cagle, Philip T.
    LABORATORY INVESTIGATION, 2017, 97 : 475A - 475A
  • [8] Significance of evaluating tumor-infiltrating lymphocytes (TILs) and programmed cell death-ligand 1 (PD-L1) expression in breast cancer
    Kurozumi, Sasagu
    Fujii, Takaaki
    Matsumoto, Hiroshi
    Inoue, Kenichi
    Kurosumi, Masafumi
    Horiguchi, Jun
    Kuwano, Hiroyuki
    MEDICAL MOLECULAR MORPHOLOGY, 2017, 50 (04) : 185 - 194
  • [9] Programmed Cell Death Ligand-1 (PD-L1) Expression in Gastrointestinal Stromal Tumors Correlates Significantly with Presence of Tumor Infiltrating Lymphocytes
    Savant, Deepika
    Vitkovski, Taisia
    Thomas, Rebecca
    Rishi, Arvind
    MODERN PATHOLOGY, 2017, 30 : 199A - 199A
  • [10] Programmed Cell Death Ligand-1 (PD-L1) Expression in Gastrointestinal Stromal Tumors Correlates Significantly with Presence of Tumor Infiltrating Lymphocytes
    Savant, Deepika
    Vitkovski, Taisia
    Thomas, Rebecca
    Rishi, Arvind
    LABORATORY INVESTIGATION, 2017, 97 : 199A - 199A